Park Square is pleased to announce the placement of Jamie Lewis as Chief Commercial Officer at Inflammatix. Inflammatix is a pioneering biotechnology company leveraging cutting-edge molecular diagnostics and AI/ML platforms to deliver precision medicine to acute care settings. The company has raised over $200 million in funding from leading investors including Khosla Ventures, Northpond Ventures, Think.Health Ventures, D1 Capital, and the Stanford-StartX Fund.

A strategic commercial executive with a proven track record of leading high-performing teams and building successful companies, Jamie will build and manage the TriVerity commercial organization. She designed and operationalized the strategy and commercial infrastructure that led Outset Medical to a successful IPO in September 2020. Previously, she served in various leadership roles at Intuitive Surgical, growing sales and market development efforts during the high-adoption phase of surgical robotics. More recently, Jamie co-founded Matter Solutions, a technology platform that is driving a coordinated care approach for providers and healthcare systems to offer virtual mental and behavioral healthcare services at scale. Jamie graduated from The Ohio State University and was team captain and a four-year starter on the Ohio State basketball team. She was the first Ohio State player drafted by the WNBA's Washington Mystics.

Lewis received her B.A. degree in Communication and Journalism Studies from The Ohio State University.